Share on StockTwits

Skyline Medical (NASDAQ:SKLN) major shareholder Samuel Herschkowitz purchased 2,000 shares of the stock in a transaction dated Tuesday, August 19th. The stock was purchased at an average price of $0.12 per share, with a total value of $240.00. Following the completion of the purchase, the insider now directly owns 46,782,377 shares in the company, valued at approximately $5,613,885. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Shares of Skyline Medical (NASDAQ:SKLN) traded up 11.15% during mid-day trading on Thursday, hitting $0.1445. The stock had a trading volume of 46,700 shares. Skyline Medical has a 1-year low of $0.106 and a 1-year high of $0.47. The stock’s 50-day moving average is $0.13 and its 200-day moving average is $0.17. The company’s market cap is $32.1 million.

Skyline Medical Inc, formerly BioDrain Medical, Inc, is an early stage medical device company. The Company owns patent rights to its products and will distribute its products to medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented, and disposed.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.